Rapid myocardial infarction test CCK-402

creatine kinasebloodimmunoassay

Product overview
The CK-MB Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human CK-MB in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).

Principle
The CK-MB Rapid Test Device is a qualitative, membrane-based immunoassay. The membrane is pre-coated with capture reagent on the test line region. During testing, the specimen reacts with particles coated with anti-CK-MB antibodies. The mixture migrates upward on the membrane by capillary action to react with capture reagent on the membrane and generate a colored line. The presence of a colored line in the test line region indicates a positive result; its absence indicates a negative result. A colored line will always appear in the control line region as a procedural control indicating that proper specimen volume has been added and membrane wicking has occurred.

Kit components

• Test devices
• Droppers
• Buffer
• Package insert

Assay reagents
The test contains anti-CK-MB antibody-coated particles and capture reagent coated on the membrane.

Technical characteristics / specifications

• Sample types: whole blood, serum, plasma
• Assay format: rapid chromatographic membrane-based immunoassay (colloidal gold/particle-conjugate)
• Intended use: qualitative detection of human CK-MB as an aid in the diagnosis of myocardial infarction (MI)
• Result readout: colored test line indicates positive; absence indicates negative; control line indicates procedural validity
• Included kit items: test devices, droppers, buffer, package insert